t-Plasminogen activator and von Willebrand factor in patients with unstable angina. 1996

D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
Cardiology Unit, Hippokration Hospital, Athens University Medical School, Greece.

We investigated whether the clinical evolution of symptoms in patients admitted with unstable angina is associated with changes in t-plasminogen activator antigen (t-PA) and von Willebrand (vW) factor levels. Concentrations of vW factor antigen and t-PA antigen were measured by an enzyme-linked immunoassay method in 10 patients who became clinically stable within 24 h of admission and remained so for 5 days. A significant rise in morning t-PA plasma level occurred 24 h after the admission (15.15 +/- 2.1 ng/ml, P < 0.05), whereas the vW factor remained unchanged. No significant changes were found in the night concentration in t-PA and vW factor during the 5 day period. Thus t-PA level is significantly raised 24 h after admission in patients with unstable angina who stabilize in response to medical treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000789 Angina, Unstable Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION. Angina at Rest,Angina, Preinfarction,Myocardial Preinfarction Syndrome,Angina Pectoris, Unstable,Unstable Angina,Angina Pectori, Unstable,Anginas, Preinfarction,Anginas, Unstable,Myocardial Preinfarction Syndromes,Preinfarction Angina,Preinfarction Anginas,Preinfarction Syndrome, Myocardial,Preinfarction Syndromes, Myocardial,Syndrome, Myocardial Preinfarction,Syndromes, Myocardial Preinfarction,Unstable Angina Pectori,Unstable Angina Pectoris,Unstable Anginas
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
September 1993, Clinical rheumatology,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
June 1992, Clinical rheumatology,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
August 1995, Thrombosis and haemostasis,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
January 2008, Thrombosis research,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
August 1992, American heart journal,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
January 1995, Scandinavian journal of rheumatology,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
February 1991, Arthritis and rheumatism,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
May 1991, Annals of the rheumatic diseases,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
June 1986, Thrombosis and haemostasis,
D Tousoulis, and E Bosinakou, and C Tentolouris, and T Apostolopoulos, and C Copshari, and M Kyriakides, and P Toutouzas
July 2012, JPMA. The Journal of the Pakistan Medical Association,
Copied contents to your clipboard!